IMMUCELL CORP /DE/ Quarterly Operating Lease, Liability in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Immucell Corp /De/ quarterly Operating Lease, Liability history and growth rate from Q1 2020 to Q2 2024.
  • Immucell Corp /De/ Operating Lease, Liability for the quarter ending June 30, 2024 was $4.58M, a 4.8% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.58M +$210K +4.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $4.66M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.72M +$2.47M +110% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $4.37M +$2.12M +94.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $4.37M +$3.29M +304% Jun 30, 2023 10-Q 2023-08-10
Q4 2022 $2.25M +$2.09M +1311% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $2.25M +$1.09M +93.8% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $1.08M -$104K -8.8% Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 $1.11M -$102K -8.46% Mar 31, 2022 10-Q/A 2022-11-21
Q4 2021 $159K -$1.08M -87.1% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $1.16M -$97.5K -7.75% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.19M -$99.4K -7.74% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.21M -$96.4K -7.38% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.24M Dec 31, 2020 10-K 2021-03-30
Q3 2020 $1.26M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.28M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $1.31M Mar 31, 2020 10-Q 2020-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.